Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Topical Hemostatic Agents market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Topical Hemostatic Agents market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Topical Hemostatic Agents market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Topical Hemostatic Agents products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Topical Hemostatic Agents products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Topical Hemostatic Agents market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Topical Hemostatic Agents development has been the leading industry trend of Topical Hemostatic Agents market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Topical Hemostatic Agents Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Gelation Sponge, Oxidized Regenerated Cellulose Based Hemostats, Others |
| By Application Outlook |
Hospitals, Surgical Centers, Nursing Homes, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Ethicon, Pfizer, Baxter International, C. R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Ethicon
- Pfizer
- Baxter International
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences
- B Braun Melsungen
- Gelita Medical
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
Topical Hemostatic Agents Market, By Type
- Gelation Sponge
- Oxidized Regenerated Cellulose Based Hemostats
- Others
Topical Hemostatic Agents Market, By Application
- Hospitals
- Surgical Centers
- Nursing Homes
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Topical Hemostatic Agents Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Topical Hemostatic Agents Market Size Growth Rate by Product
1.4.2 Gelation Sponge
1.4.3 Oxidized Regenerated Cellulose Based Hemostats
1.4.4 Others
1.5 Market by End User
1.5.1 Global Topical Hemostatic Agents Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Surgical Centers
1.5.4 Nursing Homes
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Topical Hemostatic Agents Market Size
2.1.1 Global Topical Hemostatic Agents Revenue 2017-2027
2.1.2 Global Topical Hemostatic Agents Sales 2017-2027
2.2 Topical Hemostatic Agents Growth Rate by Regions
2.2.1 Global Topical Hemostatic Agents Sales by Regions
2.2.2 Global Topical Hemostatic Agents Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Topical Hemostatic Agents Sales by Manufacturers
3.1.1 Topical Hemostatic Agents Sales by Manufacturers
3.1.2 Topical Hemostatic Agents Sales Market Share by Manufacturers
3.1.3 Global Topical Hemostatic Agents Market Concentration Ratio (CR5 and HHI)
3.2 Topical Hemostatic Agents Revenue by Manufacturers
3.2.1 Topical Hemostatic Agents Revenue by Manufacturers (2017-2020)
3.2.2 Topical Hemostatic Agents Revenue Share by Manufacturers (2017-2020)
3.3 Topical Hemostatic Agents Price by Manufacturers
3.4 Topical Hemostatic Agents Manufacturing Base Distribution, Product Types
3.4.1 Topical Hemostatic Agents Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Topical Hemostatic Agents Product Type
3.4.3 Date of International Manufacturers Enter into Topical Hemostatic Agents Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Topical Hemostatic Agents Sales by Product
4.2 Global Topical Hemostatic Agents Revenue by Product
4.3 Topical Hemostatic Agents Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Topical Hemostatic Agents Breakdown Data by End User
6 North America
6.1 North America Topical Hemostatic Agents by Countries
6.1.1 North America Topical Hemostatic Agents Sales by Countries
6.1.2 North America Topical Hemostatic Agents Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Topical Hemostatic Agents by Product
6.3 North America Topical Hemostatic Agents by End User
7 Europe
7.1 Europe Topical Hemostatic Agents by Countries
7.1.1 Europe Topical Hemostatic Agents Sales by Countries
7.1.2 Europe Topical Hemostatic Agents Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Topical Hemostatic Agents by Product
7.3 Europe Topical Hemostatic Agents by End User
8 Asia Pacific
8.1 Asia Pacific Topical Hemostatic Agents by Countries
8.1.1 Asia Pacific Topical Hemostatic Agents Sales by Countries
8.1.2 Asia Pacific Topical Hemostatic Agents Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Topical Hemostatic Agents by Product
8.3 Asia Pacific Topical Hemostatic Agents by End User
9 Central & South America
9.1 Central & South America Topical Hemostatic Agents by Countries
9.1.1 Central & South America Topical Hemostatic Agents Sales by Countries
9.1.2 Central & South America Topical Hemostatic Agents Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Topical Hemostatic Agents by Product
9.3 Central & South America Topical Hemostatic Agents by End User
10 Middle East and Africa
10.1 Middle East and Africa Topical Hemostatic Agents by Countries
10.1.1 Middle East and Africa Topical Hemostatic Agents Sales by Countries
10.1.2 Middle East and Africa Topical Hemostatic Agents Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Topical Hemostatic Agents by Product
10.3 Middle East and Africa Topical Hemostatic Agents by End User
11 Company Profiles
11.1 Ethicon
11.1.1 Ethicon Company Details
11.1.2 Company Business Overview
11.1.3 Ethicon Topical Hemostatic Agents Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Ethicon Topical Hemostatic Agents Products Offered
11.1.5 Ethicon Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Topical Hemostatic Agents Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Pfizer Topical Hemostatic Agents Products Offered
11.2.5 Pfizer Recent Development
11.3 Baxter International
11.3.1 Baxter International Company Details
11.3.2 Company Business Overview
11.3.3 Baxter International Topical Hemostatic Agents Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Baxter International Topical Hemostatic Agents Products Offered
11.3.5 Baxter International Recent Development
11.4 C. R. Bard
11.4.1 C. R. Bard Company Details
11.4.2 Company Business Overview
11.4.3 C. R. Bard Topical Hemostatic Agents Sales, Revenue and Gross Margin (2017-2020)
11.4.4 C. R. Bard Topical Hemostatic Agents Products Offered
11.4.5 C. R. Bard Recent Development
11.5 The Medicines Company
11.5.1 The Medicines Company Company Details
11.5.2 Company Business Overview
11.5.3 The Medicines Company Topical Hemostatic Agents Sales, Revenue and Gross Margin (2017-2020)
11.5.4 The Medicines Company Topical Hemostatic Agents Products Offered
11.5.5 The Medicines Company Recent Development
11.6 Anika Therapeutics
11.6.1 Anika Therapeutics Company Details
11.6.2 Company Business Overview
11.6.3 Anika Therapeutics Topical Hemostatic Agents Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Anika Therapeutics Topical Hemostatic Agents Products Offered
11.6.5 Anika Therapeutics Recent Development
11.7 Advanced Medical Solutions
11.7.1 Advanced Medical Solutions Company Details
11.7.2 Company Business Overview
11.7.3 Advanced Medical Solutions Topical Hemostatic Agents Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Advanced Medical Solutions Topical Hemostatic Agents Products Offered
11.7.5 Advanced Medical Solutions Recent Development
11.8 Integra LifeSciences
11.8.1 Integra LifeSciences Company Details
11.8.2 Company Business Overview
11.8.3 Integra LifeSciences Topical Hemostatic Agents Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Integra LifeSciences Topical Hemostatic Agents Products Offered
11.8.5 Integra LifeSciences Recent Development
11.9 B Braun Melsungen
11.9.1 B Braun Melsungen Company Details
11.9.2 Company Business Overview
11.9.3 B Braun Melsungen Topical Hemostatic Agents Sales, Revenue and Gross Margin (2017-2020)
11.9.4 B Braun Melsungen Topical Hemostatic Agents Products Offered
11.9.5 B Braun Melsungen Recent Development
11.10 Gelita Medical
11.10.1 Gelita Medical Company Details
11.10.2 Company Business Overview
11.10.3 Gelita Medical Topical Hemostatic Agents Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Gelita Medical Topical Hemostatic Agents Products Offered
11.10.5 Gelita Medical Recent Development
11.11 Equimedical
11.12 Vascular Solutions
11.13 Marine Polymer Technologies
12 Future Forecast
12.1 Topical Hemostatic Agents Market Forecast by Regions
12.1.1 Global Topical Hemostatic Agents Sales Forecast by Regions 2019-2025
12.1.2 Global Topical Hemostatic Agents Revenue Forecast by Regions 2019-2025
12.2 Topical Hemostatic Agents Market Forecast by Product
12.2.1 Global Topical Hemostatic Agents Sales Forecast by Product 2019-2025
12.2.2 Global Topical Hemostatic Agents Revenue Forecast by Product 2019-2025
12.3 Topical Hemostatic Agents Market Forecast by End User
12.4 North America Topical Hemostatic Agents Forecast
12.5 Europe Topical Hemostatic Agents Forecast
12.6 Asia Pacific Topical Hemostatic Agents Forecast
12.7 Central & South America Topical Hemostatic Agents Forecast
12.8 Middle East and Africa Topical Hemostatic Agents Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Topical Hemostatic Agents Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
